BlackRock, GMO forecast single-digit returns for U.S. stocks

High valuations, low interest rates spell lower annual returns of 5% or less; timber seen as best bet

Apr 19, 2016 @ 11:41 am

By John Waggoner

Richard Turnill, BlackRock's chief global investment strategist, has some advice for investors: Curb your enthusiasm. And he's not alone.

“We see a global portfolio made up of 60% equities and 40% fixed income producing annual returns of just 3.3% in U.S. dollars, before inflation, over the next five years,” Mr. Turnill wrote in BlackRock's most recent weekly market commentary. The outlook is worse for those who stay with U.S. assets: less than 3%, or about 1% a year after inflation.

One reason for the gloominess: Likely negative returns for long Treasury bonds and Eurozone debt as well. Low interest rates here and abroad make long-dated debt particularly vulnerable. “These assets are still important portfolio diversifiers, but the price of that diversification is rising,” Mr. Turnill warned.

Assuming a long, flat recovery — which Mr. Turnill does — stocks may well be laggards as well, at least compared to their long-term average returns. He sees U.S. stocks, large and small, as returning less than 5% annually.

Only foreign stocks, emerging markets stocks and private equity will clear 5% annual returns before inflation, Mr. Turnill said. “Our international equity return estimates are now above the long-term average, thanks to improved valuations outside the U.S.”

The GMO funds, while smaller than the $4.6 trillion BlackRock (BLK), paints a similarly gloomy picture. Historically, U.S. stocks have gained 6.5% a year after inflation. But you're going to be disappointed in the next seven years, GMO says.

In its most recent estimate of returns for the next seven years, Boston-based GMO sees large-cap U.S. stocks returning an average -2.3% a year after inflation, with large-cap international stocks gaining 1.2% annually. The best stock bet, in GMO's estimation: Emerging markets stocks, which they project will grow 4% a year after inflation.

GMO's outlook for bonds is particularly grim, with U.S. bonds losing an average 1.6% a year and currency-hedged international bonds losing 3.4%. Emerging markets debt will eke out a 1.7% average annual return, in GMO's estimation.

The best investment for the next seven years, according to GMO: timber, which they think will grow at a 4.8% pace.

Most of the gloomsayers' predications for stocks are based on earnings projections and price-to-earnings multiples. And as first-quarter earnings roll in, the picture isn't terribly pretty. Aggregate earnings for the Standard and Poor's stock index are estimated at $26.18, an 18% decline from a year earlier, and the third quarterly decline in a row, S&P says. Even excluding the desultory energy sector, earnings are projected to fall 3.4%, S&P says. And the S&P 500's price-to-earnings ratio is 17.8, using forward earnings estimates — above its 15-year average.

0
Comments

What do you think?

View comments

Recommended for you

Featured video

Events

How to improve productivity

Expanding your business can be a challenge for advisers. Tim Welsh of Nexus Strategy offers some helpful strategies to take your practice to the next level.

Latest news & opinion

The Women’s Issue

News, video and expert opinion about women in financial advice

Meet the 2018 Women to Watch

These female financial advisers and other industry leaders are recognized for their successes and support of other women in the financial advice business.

Some good news about female recruitment in financial advice

Each of four core advisory positions tracked in InvestmentNews' benchmarking study has seen an uptick in women entrants.

10 ETFs that are up more than 35% this year

Amid the stock market carnage, there are still some funds posting big gains.

10 biggest HSA providers rated

Morningstar rated the largest plan providers as investment and spending vehicles.

X

Hi! Glad you're here and we hope you like all the great work we do here at InvestmentNews. But what we do is expensive and is funded in part by our sponsors. So won't you show our sponsors a little love by whitelisting investmentnews.com? It'll help us continue to serve you.

Yes, show me how to whitelist investmentnews.com

Ad blocker detected. Please whitelist us or give premium a try.

X

Subscribe and Save 60%

Premium Access
Print + Digital

Learn more
Subscribe to Print